Laboratory of Organic & Medicinal Chemistry, Department of Chemistry, Malaviya National Institute of Technology, Jaipur, 302017, India.
School of Agriculture, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, 302017, India.
Sci Rep. 2020 Feb 11;10(1):2307. doi: 10.1038/s41598-020-59218-6.
For the first time, a series of highly potent natural product inspired substituted (Z)-3-benzylideneisobenzofuran-1(3H)-ones 28a-t, embraced with electron-withdrawing groups (EWG) and electron-donating groups (EDG) at site I and site II, were prepared and assessed for their in vitro antioxidant activities (DPPH free radical scavenging assay) and arachidonic acid (AA)-induced antiplatelet activities using ascorbic acid (IC = 4.57 µg/mL) and aspirin (IC = 21.34 µg/mL), as standard references, respectively. In this study, compounds 28f-g, 28k-l and 28q have shown high order of in vitro antioxidant activity. Infact, 28f and 28k were found to show 10-folds and 8-folds more antioxidant activity than ascorbic acid, respectively and was found to be the most active analogues of the series. Similarly, Compounds 28c-g, 28k-l, 28o and 28q-t were recognized as highly potent antiplatelet agents (upto 6-folds) than aspirin. Furthermore, in silico studies of the most active antioxidants 28f, 28k and 28l and very active antiplatelet molecules 28f, 28k, 28l and 28s were carrying out for the validation of the biological results. This is the first detailed study of the discovery of several (Z)-3-benzylideneisobenzofuran-1(3H)-ones as highly potent antioxidants and antiplatelet agents.
首次制备了一系列具有高度活性的天然产物衍生的取代(Z)-3-苄基异苯并呋喃-1(3H)-酮 28a-t,这些化合物在 I 位和 II 位上带有吸电子基团(EWG)和供电子基团(EDG),并评估了它们的体外抗氧化活性(DPPH 自由基清除测定法)和花生四烯酸(AA)诱导的抗血小板活性,以抗坏血酸(IC=4.57μg/mL)和阿司匹林(IC=21.34μg/mL)为标准参考。在这项研究中,化合物 28f-g、28k-l 和 28q 表现出高度的体外抗氧化活性。事实上,28f 和 28k 的抗氧化活性分别比抗坏血酸高 10 倍和 8 倍,被认为是该系列中最活跃的类似物。类似地,化合物 28c-g、28k-l、28o 和 28q-t 被认为是比阿司匹林更有效的抗血小板药物(高达 6 倍)。此外,对最活跃的抗氧化剂 28f、28k 和 28l 以及非常活跃的抗血小板分子 28f、28k、28l 和 28s 进行了计算机模拟研究,以验证生物学结果。这是首次详细研究发现几种(Z)-3-苄基异苯并呋喃-1(3H)-酮作为高效抗氧化剂和抗血小板药物。